← All diseases
Cancer
Esophageal cancer
Do you want to be notified when there is new research about Esophageal Cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Esophageal Cancer is available. View what Premium costs.
Publications and studies (2589)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Terminally exhausted CD8(+) T cells in solid tumors: biology, biomarker potential and translational tools for precision oncology. (2026/01/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Thoracoscopic repair of esophagogastric anastomotic fistula using a pedicled pleural flap: a case report and literature review. (2026/01/12) ♡
- Real-world clinical characteristics and outcomes of patients with locally advanced, unresectable esophageal/gastroesophageal junction cancer treated with definitive chemoradiotherapy in the United States community oncology setting. (2026/01/12) ♡
- Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology. (2026/01/12) ♡
- Exploring the Mechanism of Qigesan in Treating Esophageal Carcinoma Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation. (2026/01/12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Development and usability evaluation of a patient journey-based mHealth intervention for esophageal cancer patients: a three-phase protocol. (2026/01/09) ♡
- Sex-divergent anatomic system concordance in second primary malignant neoplasms: a large-scale analysis. (2026/01/09) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Bacterial contributions to cancer development: mechanisms, dysbiosis, and cross-cancer associations. (2026/01/08) ♡
- Predictive value of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio for three-year survival in patients with early esophageal cancer undergoing endoscopic submucosal dissection. (2026/01/07) ♡
- Efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a prospective cohort study with propensity-score matching. (2026/01/06) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Tislelizumab efficacy and safety compared to other anti-PD-1s: a network meta-analysis of first-line therapies for unresectable, locally advanced or metastatic esophageal squamous cell carcinoma. (2026/01/06) ♡
- Correction: Investigating object detection errors in endoscopic imaging of esophageal SCC and dysplasia through precision-recall analysis. (2026/01/06) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Saliva and blood miRNAs as complementary biomarkers for esophageal cancer detection. (2026/01/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Sarcoidosis misdiagnosed as pulmonary malignancy: a case report. (2026/01/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The emerging roles of METTL1-mediated tRNA m(7)G methylation in cancer development and immunotherapy. (2026/01/05) ♡
- Hepatic Fibrosis Predicts Poor Response to Preoperative Chemotherapy, Postoperative Malnutrition, and Poor Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Minimally Invasive Esophagectomy: A Retrospective Analysis. (2026/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Invited Editorial on Hepatic Fibrosis Predicts Poor Response to Preoperative Chemotherapy, Postoperative Malnutrition, and Poor Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Minimally Invasive Esophagectomy: A Retrospective Analysis. (2026/01/01) ♡
- Effectiveness of Nutritional Screening Tools in Predicting the Impact of Malnutrition on Hospital and Intensive Care Unit Stay. (2026/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Association of fat-free mass index and survival in patients with lung cancer: a multicenter cohort study. (2026/01/01) ♡
- Rab2A modulates liver fibroblast growth factor 21 (FGF21) expression and systemic metabolism via apolipoprotein B-CREBH signaling. (2026/01/01) ♡
- Gut microbiome-mediated transformation of dietary phytonutrients is associated with health outcomes. (2026/01/01) ♡
- Cancer deaths attributable to lifestyle risk factors in five Latin American countries. (2026/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Predictive Factors for Infectious Complications after Robotic Gastrectomy for Gastric or Esophagogastric Junction Cancer. (2026/01/01) ♡
- Health care professionals' perceptions of machine learning based clinical decision support systems for oesophageal cancer management. (2026/01/01) ♡
- HNF4A-AS1 promotes hepatic steatosis in metabolic dysfunction-associated steatotic liver disease by driving HNF4A degradation. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transposable elements in human cancer: Regulation, activation, and genomic consequences. (2026/01/01) ♡
- Revealing the Mechanism of Buzhong Yiqi Tang in Ameliorating Autoimmune Thyroiditis via the Toll-like Receptor Pathway. (2026/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful Combination Immunotherapy for Postoperative Recurrence of Esophageal Cancer Following Prior Immune Checkpoint Inhibitor Treatment: A Case Report. (2026/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Limitations of (18)F-FDG PET/CT in detecting direct bronchial metastasis from esophageal squamous cell carcinoma: A case report. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Roles and clinical implications of N6-methyladenosine in digestive system tumors. (2026/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer (2026-08-11) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors (2026-08-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection (2026-08-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. AI-Driven Digital Twin and Drug Simulation for Esophageal Cancer (2026-08-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma (2026-08-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Advanced Endo-therapeutic Procedure : Registry-based Observational Study (2026-08-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Ursodeoxycholic Acid in Barrett's Endotherapy (2026-08-11) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Study of MGC026 in Participants With Advanced Solid Tumors (2026-08-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. ALDH2 Genetic Testing in East Asian Community (2026-08-11) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Obeticholic Acid for Prevention in Barrett's Esophagus (2026-08-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma (2026-08-10) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors (2026-08-10) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial (2026-08-10) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06) (2026-08-07) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer (2026-08-07) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Esophageal Cancer in Northeastern Iran (2026-08-07) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery (2026-08-07) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation (2026-08-07) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer (2026-08-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer (2026-08-06) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.